United States · FDA National Drug Code directory
SAJAZIR
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70709-013_98f58ca8-04a0-4453-adf0-b000d3bcfae1
- Product NDC
- 70709-013
- Form
- INJECTION
- Composition / generic term
- ICATIBANT
- Labeler
- Cycle Pharmaceuticals Ltd-Uk
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210603
- Source listing expiry
- 20261231
Source-listed ingredients
- ICATIBANT ACETATE — 30 mg/3mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE, GLASS in 1 CARTON (70709-013-01) / 3 mL in 1 SYRINGE, GLASS · 70709-013-01
- 3 SYRINGE, GLASS in 1 CARTON (70709-013-03) / 3 mL in 1 SYRINGE, GLASS · 70709-013-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →